About Surrozen
Surrozen is a company based in San Francisco (United States) founded in 2016. Surrozen has raised $133 million across 5 funding rounds from investors including RA Capital, Hartford HealthCare and The Column Group. The company has 41 employees as of December 31, 2024. Surrozen offers products and services including Wnt Biology Platform and SWAP/SWEETS. Surrozen operates in a competitive market with competitors including Novartis, Catalent, Biotage, Curia and AmplifyBio, among others.
- Headquarter San Francisco, United States
- Employees 41 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Surrozen, Inc.
-
Annual Revenue
$10.65 M (USD)0as on Dec 31, 2024
-
Net Profit
-$63.56 M (USD)-47.68as on Dec 31, 2024
-
EBITDA
-$24.1 M (USD)41.39as on Dec 31, 2024
-
Total Equity Funding
$133 M (USD)
in 5 rounds
-
Latest Funding Round
$175 M (USD), Post-IPO
Mar 24, 2025
-
Investors
RA Capital
& 13 more
-
Employee Count
41
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Surrozen
Surrozen is a publicly listed company on the NASDAQ with ticker symbol SRZN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Surrozen
Surrozen offers a comprehensive portfolio of products and services, including Wnt Biology Platform and SWAP/SWEETS.
Platform for unlocking body's regenerative power to treat injuries and diseases
Technology for advancing treatments in regenerative medicine and disease pipelines
People of Surrozen
Unlock access to complete
Unlock access to complete
Funding Insights of Surrozen
Surrozen has successfully raised a total of $133M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $175 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Surrozen
Surrozen has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include RA Capital, Hartford HealthCare and The Column Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on tech sectors
|
Locked | Locked | Locked | |
|
Early-stage investments in US life science startups are focused on.
|
Locked | Locked | Locked | |
|
Access Biotechnology is engaged in investing in transformative biopharma therapies.
|
Locked | Locked | Locked |
Investor details for Surrozen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Surrozen
Investment portfolio details for Surrozen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Surrozen
Detailed financials for Surrozen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Surrozen Comparisons
Peer comparison for Surrozen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Surrozen
Surrozen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Biotage, Curia and AmplifyBio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| Locked | Locked | Locked |
CDMO offering drug and biologics development services
|
|
| Locked | Locked | Locked |
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
|
| Locked | Locked | Locked |
Drug research, development, testing, and consulting services are provided.
|
|
| Locked | Locked | Locked |
Provides contract research, development, and manufacturing services for biologic drugs.
|
Detailed competitors of Surrozen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Surrozen
Complete news archive for Surrozen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surrozen
Surrozen was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Surrozen is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Surrozen is a funded company, having raised a total of $133M across 5 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Surrozen is 41.
Annual revenue of Surrozen is $10.65M as on Dec 31, 2024.
Surrozen was founded in 2016 and is headquartered in San Francisco, United States. Protein therapeutics targeting the Wnt pathway are discovered and developed to support tissue repair and regeneration. A pipeline of selective agonists is constructed to enable in situ regeneration across various tissues. Roles of Wnt proteins in stem cell maintenance and developmental processes are leveraged within the biotechnology sector.
Surrozen offers Wnt Biology Platform and SWAP/SWEETS.
Yes, Surrozen is publicly traded on NASDAQ under the ticker symbol SRZN.
Surrozen has 14 investors. Key investors include RA Capital, Hartford HealthCare, The Column Group, Venrock, and Access Biotechnology.
The ticker symbol of Surrozen is SRZN on NASDAQ.